Halo Therapeutics Co-founder and CSO Imre Berger is University of Bristol Lead in EPSRC/DHSC's new 10.5Mio GBP Future Vaccine Manufactruing and Research Hub. Congratulations Imre !
Full Professor (Chair), FMedSci, Founding Director Max Planck Centre for Minimal Biology, Director BrisSynBio Centre, Wellcome Trust and ERC Investigator
Hooray for Bristol ! 10.5 Mio GBP EPSRC/DHSC Future Vaccine Manufacture and Research Hub announced ! Scientists from #Vietnam, Imperial College London and University of Bristol met representatives from the Vietnamese Ministry of Health and the Embassy of Vietnam to the UK, to celebrate in Bristol's beautiful Wills Memorial Building. Five years to develop and use cutting-edge technology to make better vaccines faster, where it matters most. The hub was announced by Minister for Health and Secondary Care Will Quince. He said: “I’m thrilled that the UK is building on its strong working relationship with global researchers by funding these innovative vaccine hubs, which will support partners across Africa and South East Asia to improve vaccine manufacturing capability." Department of Health and Social Care EPSRC UK Research and Innovation #maxplanckbristol #vaccineswork #vaccinessavelives #manufacturing #researchanddevelopment #cuttingedgetechnology #togetherwecan #togetherwewin Robin Shattock Imre Berger Nilay Shah Rongjun Chen VABIOTECH Agnes Nairn Jeremy Tavaré Elek Molnar Christiane Berger-Schaffitzel Sarah Joseph Kathleen Sedgley Bristol BioDesign Institute Biochemistry Bristol Wellcome Trust European Commission Imophoron Ltd Halo Therapeutics Evelyn Welch Rich Pitts Oracle Oracle Research